Transplantation Proceedings

Physical Function Measured Prior to Lung Transplantation Is Associated With Posttransplant Patient Outcomes.  53:288-295. 2021

Lung Transplantation for Cystic Fibrosis and Non-cystic Fibrosis Bronchiectasis: A Single-Center Experience.  51:2029-2034. 2019

Syndrome of Inappropriate Anti-Diuretic Hormone Secretion Secondary to Strongyloides stercoralis Infection in an Allogeneic Stem Cell Transplant Patient: A Case Report and Literature Review.  49:373-377. 2017

Dosing Eculizumab for Antibody-Mediated Rejection in Kidney Transplantation: A Case Report.  48:3099-3105. 2016

Recurrent IgA Nephropathy After Kidney Transplantation.  48:2689-2694. 2016

Cardiac Donor Risk Factors Predictive of Short-Term Heart Transplant Recipient Mortality: An Analysis of the United Network for Organ Sharing Database.  47:2944-2951. 2015

Falsely incompatible b-cell flow cytometry crossmatch after pronase treatment: A case report.  47:831-833. 2015

Survey of First-Year Medical Students to Assess Their Knowledge and Attitudes Toward Organ Transplantation and Donation.  41:634-638. 2009

Can Machine Perfusion Decrease the Likelihood of Discard Among Biopsied Kidneys?.  40:1029-1031. 2008

A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients.  37:4303-4305. 2005

A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: The cincinnati experience.  37:802-803. 2005

Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression.  37:800-801. 2005

Chemotherapy for posttransplant lymphoproliferative disorder: The Israel Penn International Transplant Tumor Registry Experience.  37:956-957. 2005

Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy.  37:795-797. 2005

De novo colorectal cancer: Five-year survival is markedly lower in transplant recipients compared with the general population.  37:960-961. 2005

Donor kidneys with small renal cell cancers: Can they be transplanted?.  37:581-582. 2005

Early corticosteroid withdrawal under modern immunosuppression in renal transplantation: Multivariate analysis of risk factors for acute rejection.  37:798-799. 2005

Early steroid withdrawal does not increase risk for recurrent focal segmental glomerulosclerosis.  37:817-818. 2005

Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantation.  37:812-813. 2005

Histocompatibility testing predicts acute rejection risk in early corticosteroid withdrawal regimens.  37:809-811. 2005

Laparoscopic living donor nephrectomy for kidneys with multiple arteries.  37:629-630. 2005

Laparoscopic right living donor nephrectomy.  37:631-632. 2005

Methicillin-resistant Staphylococcus aureus infection in liver transplantation: A matched controlled study.  37:1243-1244. 2005

Pilot study of early corticosteroid elimination after pancreas transplantation.  37:1287-1288. 2005

Posttransplant lymphoproliferative disorder: Significance of central nervous system involvement.  37:954-955. 2005

Prostate cancer prior to solid organ transplantation: The Israel Penn International Transplant Tumor Registry Experience.  37:958-959. 2005

Skin cancer following transplantation: The Israel Penn International Transplant Tumor Registry experience.  37:962-963. 2005

De novo breast cancer in renal transplant recipients.  34:1778-1779. 2002

De novo sarcomas in solid organ transplant recipients.  34:1786-1787. 2002

Delay of hepatitis C recurrence in liver transplant recipients: Impact of mycophenolate mofetil on transplant recipients with severe acute rejection or with renal dysfunction.  34:1561-1562. 2002

Gastric cancer in transplant recipients: Detection of malignacy by aggressive endoscopy.  34:1784-1785. 2002

Immunosuppression and merkel cell cancer.  34:1780-1781. 2002

Impact of noncompliance and donor/recipient race matching on chronic liver rejection.  34:1497-1498. 2002

Is there a need for surveillance endomyocardial biopsies in heart transplantation?.  34:1857-1859. 2002

Polyomavirus in kidney and kidney-pancreas transplantation: A defined protocol for immunosuppression reduction and histologic monitoring.  34:1788-1789. 2002

Recurrence of hepatitis C in liver transplant recipients treated with mycophenolate mofetil.  34:1563-1564. 2002

Transplantation without steroids.  34:2076-2078. 2002

Biologic behavior of carcinoid tumors in solid organ transplant recipients: The Israel Penn international transplant tumor registry experience.  33:3656-3657. 2001

Flow panel reactive antibody monitoring following heart transplantation.  33:3295-3297. 2001

Kaposi sarcoma: An analysis of the US and international experiences from the Israel Penn international transplant tumor registry.  33:3660-3661. 2001

Erratum: Potential utility of rapamycin and tacrolimus in long-term, low-toxicity regimens (Transplantation Proceedings Vol. 31 (Suppl. 8A) (1999) (17S-22S)).  32:503-504. 2000

Construction of a recombinant adenovirus vector encoding Fas ligand with a CRE/Loxp inducible system.  31:792-793. 1999

Potential utility of rapamycin and tacrolimus in long-term, low-toxicity regimens.  31:17-22. 1999

Race is not a critical factor in orthotopic liver transplantation..  29:3729-3730. 1997

Recurrent or persistent cardiac allograft rejection: therapeutic options and recommendations..  29:40S-44S. 1997

Renal transplantation in African-American recipients: three decades at a single center..  29:3726-3728. 1997

Molecular screening of xenodonor genomes for species-specific endogenous retroviral DNA sequences.  29:897-898. 1997

Recurrent or persistent cardiac allograft rejection: Therapeutic options and recommendations.  29:40S-44S. 1997

Molecular conjugate-mediated gene transfer in renal transplantation.  28:2046-2048. 1996

Class I and class II antigens in the rejection of murine islet cell transplants.  27:3234-3235. 1995

Functional effects of transplanted human fetal ventral mesencephalic brain tissue from spontaneous abortions into a rodent model of Parkinson's disease.  26:3335. 1994

RS-61443: A new immunosuppressive agent.  26:3144-3146. 1994

Effects of total parenteral nutrition on intestinal morphology and function in humans.  26:1457. 1994

Are black living-related renal donors at greater long-term risk of renal complications than white donors?.  23:1328-1329. 1991

Comparison of simple hypothermic storage, pulsatile perfusion with Belzer's gluconate-albumin solution, and pulsatile perfusion with UW solution for renal allograft preservation.  23:2394-2395. 1991

Recent advances in the identification of significant human cytomegalovirus-encoded proteins.  23:64-69. 1991

Age: A major determinant of renal dysfunction.  22:365-367. 1990

Pulsatile perfusion preservation: Early posttransplant dialysis requirement predicts rapid graft loss.  22:446-447. 1990

The exocrine secretions of the grafted pancreas.  21:3449-3451. 1989

A parametric analysis of the hazard of cancer after transplantation.  21:3201-3204. 1989

Early graft function in primary and regraft recipients of paired cadaveric kidneys.  21:1274-1275. 1989

Lymphocytic IgM antibody in highly sensitized (>50% PRA) autologous negative renal allograft candidates.  21:739-741. 1989

Successful renal allografts in recipients with a positive standard, DTE negative cross-match.  21:746-747. 1989

Sustained high panel reactive antibody levels in highly sensitized patients: Significance of continued transfusions.  21:771-772. 1989

Use of cryopreserved donor bone marrow in cadaver kidney allograft recipients.  21:1787-1789. 1989

Induction of suppressor T cells by cytokines.  20:1156-1157. 1988

Cyclosporine impairs the renal response to volume depletion.  20:568-571. 1988

Cyclosporine neurotoxicity in liver transplant recipients: Report of three cases.  20:116-118. 1988

Early graft loss in cyclosporine A-treated cadaveric renal allograft recipients receiving retransplants against previous mismatched HLA-A, -B, -DR donor antigens.  20:170-172. 1988

Preservation by pulsatile perfusion improves early renal allograft function.  20:865-868. 1988

Unusual functional and biochemical properties of DR molecules from the HLA-DR1, B14 haplotype.  19:851-857. 1987

Quadruple immunosuppressive therapy in whole pancreas transplantation..  19:2297-2299. 1987

Quadruple therapy for cadaver renal transplantation..  19:1917-1919. 1987

Unusual functional and biochemical properties of DR molecules from the HLA-DR1, B14 haplotype..  19:851-857. 1987

A technique for transplantation of a large adult kidney into an infant.  19:2953-2955. 1987

Cadaver donor renal transplantation in insulin-dependent diabetics using cyclosporine and antilymphoblast globulin.  18:1720-1723. 1986

Sequential antilymphocyte globulin cyclosporine therapy in cadaver renal transplantation.  18:16-18. 1986

Two haplotype mismatched live donor renal transplantation in diabetics.  18:1730-1732. 1986

Analysis of flow cytometry and cytotoxicity crossmatches in renal transplantation.  17:2480-2481. 1985

HLA restriction patterns of trinitrophenyl-specific proliferative human T cell clones.  17:972-977. 1985

Use of cell line K562 and autologous B lymphoblastoid cell lines to identify and remove autoantibodies from the serum of renal patients.  17:171-173. 1985

Correlation of B-cell antibodies and clinical course in DRw-typed renal allograft recipients.  13:942-944. 1981

The quality of life after liver transplantation.  11:252-256. 1979

Outcome of renal transplantation in patients with primary cytomegalovirus infection.  11:1288-1290. 1979

Suppressor T cells in the regulation of immune responses to allogeneic tissues.  10:19-22. 1978

Early recognition of chronic humoral rejection in long-term follow-up of kidney recipients by a comprehensive renal radionuclide study..  9:43-47. 1977

Serologic detection of antigens controlled by the Ir region of the H-2 complex in the mouse..  5:1811-1813. 1973